Cited by 446Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Quantitative assessment of cortical synaptic density in Alzheimer's disease

Scheff, Stephen W., DeKosky, Steven T., Price, Douglas A.·1990·Neurobiology of Aging

DOI 10.1016/0197-4580(90)90059-9

Open this paper in CoChat — free account

Abstract

Significant progress has been made over the last decade in delineating the neuropathological and neurochemical changes in the brains of patients with Alzheimer's disease (AD). Less well studied are the actual synaptic connections of affected areas of the brain, such as the cerebral cortex. Because the final common pathway for neurotransmission involves synaptic integrity, we quantitatively assessed synaptic number and synapse size in lamina III and V of human frontal cortex (Brodmann area 9) in patients with AD and age-matched controls. Samples were also matched for postmortem interval, and artifacts associated with postmortem change were eliminated. We found a significant decrease in synaptic number per unit volume in both lamina, more marked in lamina III (-42%) than V (-29%). In both normal controls and AD brains, there was a negative correlation between synapse number and synapse size as indexed by the length of the postsynaptic density (PSD); cortical samples with fewer synapses had larger synapse size. This appeared to be a compensatory response, rather than a selective loss of small synapses, since the total amount of synaptic contact area per unit volume did not decline in lamina V (despite a 29% loss of synapses); in lamina III it was reduced 11% despite a 42% loss of synapses. The loss of synapses in AD is widespread and significant in frontal cortex; there is observable compensation by enlargement of synaptic size. This compensatory effort is overcome by the continuing loss of synapses in areas most affected by the degeneration.

Integrity signals

Registry

Crossref · 10.1016/0197-4580(90)90059-9

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 27,137
Statistical Principles in Experimental Design
Myers, J. L., & Winer, B. J. (1964) · The American Journal of Psychology · doi:10.2307/1419292 · Cited by 8,111
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
Synaptic density in human frontal cortex —Developmental changes and effects of aging
Peter R., H. (1979) · Brain Research · doi:10.1016/0006-8993(79)90349-4 · Cited by 2,645
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
The Clinical Diagnosis of Alzheimer's Disease
Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C. S., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,416
Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa
Davies, P., Katzman, R., & Terry, R. D. (1980) · Nature · doi:10.1038/288279a0 · Cited by 882
Some morphometric aspects of the brain in senile dementia of the alzheimer type
Terry, R. D., Peck, A., DeTeresa, R., Schechter, R., & Horoupian, D. S. (1981) · Annals of Neurology · doi:10.1002/ana.410100209 · Cited by 801

Show all 41 references

Sorted by citations

Items 101–200 of 445

Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
Götz, J., Ittner, L. M., & Kins, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03955.x · Cited by 119
Posttranslational modifications of α-tubulin in alzheimer disease
Zhang, F., Su, B., Wang, C., Siedlak, S. L., Mondragón‐Rodríguez, S., Lee, H., Wang, X., Perry, G. L., & Zhu, X. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0030-4 · Cited by 116
Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease
Penzes, P., & VanLeeuwen, J. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.01.003 · Cited by 121
Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease
Um, J. W., & Strittmatter, S. M. (2013) · Prion · doi:10.4161/pri.22212 · Cited by 115
Mitochondrial aging and dysfunction in Alzheimer's disease
Sullivan, P. G., & Brown, M. R. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.12.007 · Cited by 114
Altered synaptic function in Alzheimer's disease
Bell, K. F. S., & Cuello, A. C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.045 · Cited by 117
ADDLs and the signaling web that leads to Alzheimer’s disease
Krafft, G. A., & Klein, W. L. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.012 · Cited by 113
Neuronal Structure is Altered by Amyloid Plaques
Spires‐Jones, T. L., & Hyman, B. T. (2004) · Reviews in the Neurosciences · doi:10.1515/revneuro.2004.15.4.267 · Cited by 108
A BEHAVIORAL AND HISTOLOGICAL STUDY OF THE EFFECTS OF LONG-TERM EXPOSURE OF ADULT RATS TO ALUMINUM
Miu, A. C., Andreescu, C. E., Vasiu, R., & Olteanu, A. I. (2003) · International Journal of Neuroscience · doi:10.1080/00207450390232292 · Cited by 109
Synaptic Dysfunction in Alzheimer’s Disease
Marcello, E. E., Epis, R., Saraceno, C., & Luca, M. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_25 · Cited by 115
Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q
Spurrier, J., Nicholson, L., Fang, X. T., Stoner, A. J., Toyonaga, T., Holden, D., Siegert, T. R., Laird, W., Allnutt, M. A., Chiasseu, M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abi8593 · Cited by 114
An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease.
Masliah, E., Mallory, M. E., Hansen, L. A., Alford, M. F., DeTeresa, R. M., & Terry, R. D. (1993) · PubMed · Cited by 107
PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research
Bao, W., Xie, F., Zuo, C., Guan, Y., & Huang, Y. H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.624330 · Cited by 102
Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance
Geula, C., Dunlop, S. R., Ayala, I., Kawles, A. S., Flanagan, M. E., Gefen, T., & Mesulam, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15471 · Cited by 102
Visual feedback has differential effects on reaching movements in Parkinson’s and Alzheimer’s disease
Ghilardi, M.-F., Alberoni, M., Rossi, M., Franceschi, M., Mariani, C., & Fazio, F. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02635-4 · Cited by 102
Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
Lista, S., & Hampel, H. J. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1204234 · Cited by 103
Aged Non‐Human Primates: An Animal Model of Age‐Associated Neurodegenerative Disease
Price, D. L., Martin, L. J., Sisodia, S. S., Wagster, M. V., Koo, E. H., Walker, L. C., Koliatsos, V. E., & Cork, L. C. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00672.x · Cited by 100
The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease
Jembrek, M. J., Slade, N., Hof, P. R., & Šimić, G. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.05.001 · Cited by 101
Amygdala cell loss and atrophy in Alzheimer's disease
Scott, S. A., Sparks, D. L., Scheff, S. W., DeKosky, S. T., & Knox, C. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320412 · Cited by 107
[18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses
Mulholland, G. K., Wieland, D. M., Kilbourn, M. R., Frey, K. A., Sherman, P. S., Carey, J. E., & Kuhl, D. E. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199811)30:3 · Cited by 100
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment
Sager, K. L., Wuu, J., Leurgans, S. E., Rees, H. D., Gearing, M., Mufson, E. J., Levey, A. I., & Lah, J. J. (2007) · Annals of Neurology · doi:10.1002/ana.21190 · Cited by 96
Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice
Šakić, B., Szechtman, H., Denburg, J. A., Gorny, G., Kolb, B., & Whishaw, I. Q. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00085-x · Cited by 96
Tau-mediated synaptic damage in Alzheimer’s disease
Jadhav, S., Cubinkova, V., Zimova, I., Brezováková, V., Maďari, A., Cigánková, V., & Žilka, N. (2015) · Translational Neuroscience · doi:10.1515/tnsci-2015-0023 · Cited by 97
Amyloid plaque formation precedes dendritic spine loss
Bittner, T., Burgold, S., Dorostkar, M. M., Fuhrmann, M., Wegenast‐Braun, B. M., Schmidt, B., Kretzschmar, H. A., & Herms, J. W. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1047-8 · Cited by 97
Impaired metabolic activation in Alzheimer's disease: A pet study during continuous visual recognition
Kessler, J., Herholz, K., Grond, M., & Heiss, W. (1991) · Neuropsychologia · doi:10.1016/0028-3932(91)90084-l · Cited by 93
Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease
Initiative, T. A. D. N., Zhang, H., Therriault, J., Kang, M. S., Ng, K. P., Pascoal, T. A., Rosa‐Neto, P., & Gauthier, S. G. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0407-6 · Cited by 97
Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer’s disease
Samuraki, M., Matsunari, I., Chen, W.-P., Yajima, K., Yanase, D., Fujikawa, A., Takeda, N., Nishimura, S., Matsuda, H., & Yamada, M. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0454-x · Cited by 92
Vasopressin and developmental onset of flank marking behavior in golden hamsters
Ferris, C. F., Delville, Y., Brewer, J. A., Mansour, K., Yules, B., & Melloni, R. H. (1996) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(199606)30:2 · Cited by 29
The impact of Aβ-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice
Hu, L., Wong, T. P., Côté, S. L., Bell, K. F. S., & Cuello, A. C. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00394-4 · Cited by 90
ACSS2-dependent histone acetylation improves cognition in mouse model of Alzheimer’s disease
Lin, Y., Lin, A., Cai, L., Huang, W., Yan, S., Wei, Y., Ruan, X., Fang, W., Dai, X., Cheng, J., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00625-4 · Cited by 99
Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer’s disease
Montero‐Crespo, M., Domínguez-Álvaro, M., Alonso‐Nanclares, L., DeFelipe, J., & Blázquez‐Llorca, L. (2020) · Brain · doi:10.1093/brain/awaa406 · Cited by 89
Selective loss of synaptic proteins in Alzheimer's disease: Evidence for an increased severity with APOE ɛ4
Tannenberg, R. K., Scott, H. L., Tannenberg, A. E. G., & Dodd, P. R. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.05.004 · Cited by 89
Morphological plasticity of synaptic mitochondria during aging
Bertoni–Freddari, C., Fattoretti, P., Casoli, T., Spagna, C., Meier-Ruge, W. A., & ULRICH, J. (1993) · Brain Research · doi:10.1016/0006-8993(93)90955-m · Cited by 89
Nerve Growth Factor and Alzheimer's Disease
Scott, S. A., & Crutcher, K. A. (1994) · Reviews in the Neurosciences · doi:10.1515/revneuro.1994.5.3.179 · Cited by 89
Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain
Arendt, T. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00216-5 · Cited by 91
Visual cortex in Alzheimer's disease: Occurencee of neuronal death and glial proliferation, and correlation with pathological hallmarks
Leuba, G., & Kraftsik, R. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90142-2 · Cited by 88
Intersection between metabolic dysfunction, high fat diet consumption, and brain aging
Uranga, R. M., Bruce‐Keller, A. J., Morrison, C. D., Fernandez‐Kim, S. O., Ebenezer, P. J., Zhang, L., Dasuri, K., & Keller, J. N. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06803.x · Cited by 90
Tau protein is involved in morphological plasticity in hippocampal neurons in response to BDNF
Chen, Q., Zhou, Z., Zhang, L., Wang, Y., Zhang, Y., Zhong, M., Xu, S., Chen, C., Li, L., & Yu, Z. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.12.013 · Cited by 98
Axonal Transport Defects in Alzheimer’s Disease
Wang, Z., Tan, L., & Yu, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8810-x · Cited by 92
Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease
Canas, P. M., Simões, A. P., Rodrigues, R. J., & Cunha, R. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.026 · Cited by 86
Reduction of O-LinkedN-Acetylglucosamine-Modified Assembly Protein-3 in Alzheimer’s Disease
Yao, P. J., & Coleman, P. D. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02399.1998 · Cited by 85
Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer’s disease
Richardson, J. C., Kendal, C., Anderson, R., Priest, F., Gower, E., Soden, P. E., Gray, R., Topps, S., Howlett, D. R., Lavender, D., et al. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00389-0 · Cited by 85
Role of Synucleins in Alzheimer’s Disease
Crews, L. A., Tsigelny, I. F., Hashimoto, M., & Masliah, E. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9073-6 · Cited by 85
Abnormally phosphorylated tau protein in Alzheimer's disease: Heterogeneity of individual regional distribution and relationship to clinical severity
Holzer, M., Holzapfel, H.-P., Zedlick, D., Brückner, M. K., & Arendt, T. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90546-0 · Cited by 83
Vitamin D-binding protein interacts with Aβ and suppresses Aβ-mediated pathology
Moon, M., Song, H., Hong, H. J., Nam, D. W., Cha, M.-Y., Oh, M. S., Yu, J., Ryu, H., & Mook‐Jung, I. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.161 · Cited by 83
Quantitative assessment of possible age-related change in synaptic numbers in the human frontal cortex
Scheff, S. W., PRICE, D. A., & Sparks, D. L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00222-6 · Cited by 82
Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease
Nunes, M. A., Schöwe, N. M., Monteiro-Silva, K. C., Baraldi-Tornisielo, T., Souza, S. I. G., Balthazar, J., Albuquerque, M. S., Caetano, A. L., Viel, T. A., & Buck, H. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142267 · Cited by 85
Quantitative assessment of synaptic density in the entorhinal cortex in Alzheimer's disease
Scheff, S. W., Sparks, D. L., & PRICE, D. A. (1993) · Annals of Neurology · doi:10.1002/ana.410340309 · Cited by 83
Movement-Related Electroencephalographic Reactivity in Alzheimer Disease
Babiloni, C., Babiloni, F., Carducci, F., Febo Cincotti, A., Percio, C. D., Pino, G. D., Maestrini, S., Priori, A., Tisei, P., Zanetti, O. O., et al. (2000) · NeuroImage · doi:10.1006/nimg.2000.0602 · Cited by 80
Three-dimensional analysis of synapses in the transentorhinal cortex of Alzheimer’s disease patients
Domínguez-Álvaro, M., Montero-Crespo, M., Blazquez-Llorca, L., Insausti, R., DeFelipe, J., & Alonso-Nanclares, L. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0520-6 · Cited by 79
Nitrone-based therapeutics for neurodegenerative diseases: Their use alone or in combination with lanthionines
Floyd, R. A., Neto, H. C. C. F., Zimmerman, G. A., Hensley, K., & Towner, R. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.033 · Cited by 80
Quantitative EEG and dynamic susceptibility contrast MRI in Alzheimer's disease: a correlative study
Mattia, D., Babiloni, F., Romigi, A., Cincotti, F., Bianchi, L., Sperli, F., Placidi, F., Bozzao, A., Giacomini, P., Floris, R., et al. (2003) · Clinical Neurophysiology · doi:10.1016/s1388-2457(03)00085-3 · Cited by 80
Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy
Pramanik, S., Sulistio, Y. A., & Heese, K. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0214-7 · Cited by 77
AAV2 mediated retrograde transduction of corticospinal motor neurons reveals initial and selective apical dendrite degeneration in ALS
Jara, J. H., Villa, S. R., Khan, N. A., Bohn, M. C., & Özdinler, P. H. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.036 · Cited by 80
N-methyl-d-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease
Ułas, J., Brunner, L. C., Geddes, J. W., Choe, W. S., & Cotman, C. W. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90075-d · Cited by 75
The prefrontal–limbic network in depression: A core pathology of synapse regression
Bennett, M. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.001 · Cited by 79
Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas
Arendt, T., Brückner, M. K., Bigl, V., & Marcova, L. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903510204 · Cited by 72
Leptin signaling and Alzheimer's disease.
Marwarha, G., & Ghribi, O. (2012) · Europe PMC (PubMed Central) · Cited by 73
Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer’s disease at various cognitive stages
Poirel, O., Mella, S., Videau, C., Ramet, L., Davoli, M. A., Herzog, É., Katsel, P., Mechawar, N., Haroutunian, V. H., Epelbaum, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19154-y · Cited by 72
Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease
Vargas, L. M., Cerpa, W. F., Muñoz, F. J., Zanlungo, S., & Alvarez, A. R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.023 · Cited by 71
The cytoskeleton in Alzheimer disease
Terry, R. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_12 · Cited by 70
Complement C1q and C3 mRNA expression in the frontal cortex of Alzheimer's patients
Fischer, B. E., Schmoll, H., Platt, D., Popa‐Wagner, A., Riederer, P. F., & Bauer, J. (1995) · Journal of Molecular Medicine · doi:10.1007/bf00202265 · Cited by 68
Neurodegeneration and plasticity
Arendt, T. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.07.007 · Cited by 69
Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice
Boncristiano, S., Calhoun, M. E., Howard, V., Bondolfi, L., Kaeser, S. A., Wiederhold, K.-H., Staufenbiel, M., & Jucker, M. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.06.010 · Cited by 68
The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer’s Disease Neuropathology
Canu, N., Amadoro, G., Triaca, V., Latina, V., Sposato, V., Corsetti, V., Severini, C., Ciotti, M. T., & Calissano, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061319 · Cited by 70
Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease
Arendt, T. (2001) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(01)00007-7 · Cited by 66
Synapse loss in anterior horn neurons in amyotrophic lateral sclerosis
Sasaki, S., & Maruyama, S. (1994) · Acta Neuropathologica · doi:10.1007/bf00293397 · Cited by 69
Alzheimer's disease-related synapse loss in the cingulate cortex
Scheff, S. W., & PRICE, D. A. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3509 · Cited by 68
Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer’s disease
Ubhi, K., Rockenstein, E., Vazquez‐Roque, R., Mante, M., Inglis, C., Patrick, C., Adame, A., Fahnestock, M., Doppler, E., Novak, P., et al. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23142 · Cited by 65
Gene expression parallels synaptic excitability and plasticity changes in Alzheimer’s disease
Saura, C. A., Parra‐Damas, A., & Enríquez-Barreto, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00318 · Cited by 65
Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?
Dam, D. V., Vermeiren, Y., Dekker, A. D., Naudé, P. J. W., & Deyn, P. P. D. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160502123607 · Cited by 68
Rpph1 Upregulates CDC42 Expression and Promotes Hippocampal Neuron Dendritic Spine Formation by Competing with miR-330-5p
Cai, Y., Sun, Z., Jia, H., Luo, H., Ye, X., Wu, Q., Xiong, Y., Zhang, W., & Wan, J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00027 · Cited by 66
Protein Tau: Prime Cause of Synaptic and Neuronal Degeneration in Alzheimer's Disease
Crespo‐Biel, N., Theunis, C., & LEUVEN, F. V. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/251426 · Cited by 69
Vulnerability of Synaptosomes from ApoE Knock-Out Mice to Structural and Oxidative Modifications Induced by Aβ(1−40): Implications for Alzheimer's Disease
Lauderback, C. M., Hackett, J. M., Keller, J. N., Varadarajan, S., Szweda, L. I., Kindy, M. S., Markesbery, W. R., & Butterfield, D. A. (2001) · Biochemistry · doi:10.1021/bi002312k · Cited by 63
A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain.
Alford, M. F., Masliah, E., Hansen, L. A., & Terry, R. D. (1994) · Journal of Histochemistry & Cytochemistry · doi:10.1177/42.2.8288869 · Cited by 63
Evidence for altered dendritic spine compartmentalization in Alzheimer’s disease and functional effects in a mouse model
Androuin, A., Potier, B., Nägerl, U. V., Cattaert, D., Danglot, L., Thierry, M., Youssef, I., Triller, A., Duyckaerts, C. J., Hachimi, K. H. E., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1847-6 · Cited by 66
A New Tacrine–Melatonin Hybrid Reduces Amyloid Burden and Behavioral Deficits in a Mouse Model of Alzheimer’s Disease
Spuch, C., Antequera, D., Fernández‐Bachiller, M. I., Rodrı́guez-Franco, M. I., & Carro, E. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9121-2 · Cited by 62
A preclinical perspective on the enhanced vulnerability to Alzheimer's disease after early-life stress
Hoeijmakers, L., Lesuis, S. L., Krugers, H. J., Lucassen, P. J., & Kőrösi, A. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.02.003 · Cited by 66
Tau misfolding efficiently propagates between individual intact hippocampal neurons
Hallinan, G. I., Vargas-Caballero, M., West, J., & Deinhardt, K. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1590-19.2019 · Cited by 59
An Analysis of Contemporary Morphological Concepts of Synaptic Remodelling in the CNS: Perforated Synapses Revisited
Jones, D. G., & Harris, R. J. (1995) · Reviews in the Neurosciences · doi:10.1515/revneuro.1995.6.3.177 · Cited by 61
siRNA targeted against amyloid precursor protein impairs synaptic activity in vivo
Hérard, A., Besret, L., Dubois, A., Dauguet, J., Delzescaux, T., Hantraye, P., Bonvento, G., & Moya, K. L. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.020 · Cited by 61
NEUROPATHOLOGY OF ALZHEIMER'S DISEASE AND RELATED DISORDERS
Perl, D. P. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70229-2 · Cited by 60
Competing Endogenous RNA Regulations in Neurodegenerative Disorders: Current Challenges and Emerging Insights
Cai, Y., & Wan, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00370 · Cited by 59
Aberrancies in signal transduction and cell cycle related events in Alzheimer’s disease
Arendt, T., Holzer, M., Gärtner, U., & Brückner, M. K. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_14 · Cited by 58
Psychotic Symptoms in Alzheimer's Disease Are Not Associated With More Severe Neuropathologic Features
Sweet, R. A., Hamilton, R. L., López, O. L., Klunk, W. E., Wisniewski, S. R., Kaufer, D., Healy, M. T., & DeKosky, S. T. (2000) · International Psychogeriatrics · doi:10.1017/s1041610200006657 · Cited by 57
Reduced O-glycosylated clathrin assembly protein AP180: implication for synaptic vesicle recycling dysfunction in Alzheimer's disease
Yao, P. J., & Coleman, P. D. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00547-3 · Cited by 57
Pharmacologic treatment of cognition in Alzheimer's dementia
Farlow, M. R., & Evans, R. M. (1998) · Neurology · doi:10.1212/wnl.51.1_suppl_1.s36 · Cited by 56
Linking cell-cycle dysfunction in Alzheimer's disease to a failure of synaptic plasticity
Arendt, T., & Brückner, M. K. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.12.005 · Cited by 56
Interacting influences of aging and Alzheimer's disease on circadian rhythms
Duncan, M. J. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14358 · Cited by 55
Synaptic frailty and clathrin-mediated synaptic vesicle trafficking in Alzheimer's disease
Yao, P. J. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.10.012 · Cited by 56
Induced Pluripotent Stem Cell-Derived Neural Precursors Improve Memory, Synaptic and Pathological Abnormalities in a Mouse Model of Alzheimer’s Disease
Armijo, E., Edwards, G. A., Flores, A., Vera, J. R., Shahnawaz, M., Moda, F., González, C., Sanhueza, M., & Soto, C. A. (2021) · Cells · doi:10.3390/cells10071802 · Cited by 57
PET Imaging for Early Detection of Alzheimer’s Disease
Bao, W., Jia, H., Finnema, S. J., Cai, Z., Carson, R. E., & Huang, Y. H. (2017) · PET Clinics · doi:10.1016/j.cpet.2017.03.001 · Cited by 54
Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer’s Disease
Buchanan, H. M., Mackay, M., PALMER, K., Tothová, K., Katsur, M., Platt, B., & Koss, D. J. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01950-1 · Cited by 58
Synaptic Compensatory Plasticity in Alzheimer’s Disease
Bhembre, N., Bonthron, C., & Opazo, P. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0379-23.2023 · Cited by 56
Neuropathology of Depression in Alzheimer's Disease: Current Knowledge and the Potential for New Treatments
Khundakar, A. A., & Thomas, A. J. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-148003 · Cited by 53
Evaluation of Functional Decline in Alzheimer’s Dementia Using 3D Deep Learning and Group ICA for rs-fMRI Measurements
Qureshi, M. N. I., Ryu, S., Song, J., Lee, K. H., & Lee, B. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00008 · Cited by 53
Type-2 alkenes mediate synaptotoxicity in neurodegenerative diseases
LoPachin, R. M., Gavin, T., & Barber, D. S. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.04.016 · Cited by 53
Synaptic numbers across cortical laminae and cognitive performance of the rat during ageing
Wong, T. P., Campbell, P. M., Ribeiro‐da‐Silva, A., & Cuello, A. C. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00485-5 · Cited by 53
The synaptic protein NACP is abnormally expressed during the progression of Alzheimer' s disease
Iwai, A., Masliah, E., Sundsmo, M. P., DeTeresa, R. M., Mallory, M. E., Salmon, D. P., & Saitoh, T. (1996) · Brain Research · doi:10.1016/0006-8993(96)00014-5 · Cited by 51
Hippocampal excitatory amino acid receptors in elderly, normal individuals and those with Alzheimer's disease: Non-N-methyl-d-aspartate receptors
Geddes, J. W., Ułas, J., Brunner, L. C., Choe, W. S., & Cotman, C. W. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90379-g · Cited by 52

Authors: Scheff, S. W., DeKosky, S. T., & Price, D. A.
Affiliations: University of Kentucky (US)
Corresponding author: Scheff, Stephen W.
ORCID: DeKosky, Steven T.
Price, Douglas A.
Venue: Neurobiology of Aging
Publisher: Elsevier BV
Published: 1990-01
Volume: 11
Issue: 1
Pages: 29-37
ISSN: 0197-4580 (ISSN-L)
DOI: 10.1016/0197-4580(90)90059-9
OpenAlex: W2083752135
Cited by: 446
References: 41
Citations by year: 2026: 7 · 2025: 13 · 2024: 14 · 2023: 19 · 2022: 16 · 2021: 14 · 2020: 19 · 2019: 14 · 2018: 15 · 2017: 12 · 2016: 17 · 2015: 21 · 2014: 13 · 2013: 16 · 2012: 16
FWCI: 9.93
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neurobiology of Aging (publishedVersion)
PubMed (publishedVersion)
Funders: University of Kentucky
National Institute on Aging (P50AG005144, AG-05144, P01AG005119, AG0 5119)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: Alzheimer's disease, synaptic density, synapse size, postsynaptic density, frontal cortex, Brodmann area 9, cortical layers, synaptic loss, postmortem interval, neuropathology
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Cell Count, Cerebral Cortex, Female, Humans, Male, Middle Aged, Nerve Degeneration, Synapses, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Quantitative assessment of cortical synaptic density in Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks